MedCap Management
Management criteria checks 4/4
MedCap's CEO is Anders Dahlberg, appointed in Nov 2020, has a tenure of 5.67 years. total yearly compensation is SEK6.06M, comprised of 51.5% salary and 48.5% bonuses, including company stock and options. directly owns 0.27% of the company’s shares, worth €2.02M. The average tenure of the management team and the board of directors is 5.7 years and 4.2 years respectively.
Key information
Anders Dahlberg
Chief executive officer
SEK 6.1m
Total compensation
| CEO salary percentage | 51.53% |
| CEO tenure | 5.7yrs |
| CEO ownership | 0.3% |
| Management average tenure | 5.7yrs |
| Board average tenure | 4.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2026 | n/a | n/a | SEK 241m |
| Mar 31 2026 | n/a | n/a | SEK 225m |
| Dec 31 2025 | SEK 6m | SEK 3m | SEK 220m |
| Sep 30 2025 | n/a | n/a | SEK 197m |
| Jun 30 2025 | n/a | n/a | SEK 199m |
| Mar 31 2025 | n/a | n/a | SEK 202m |
| Dec 31 2024 | SEK 5m | SEK 3m | SEK 207m |
| Sep 30 2024 | n/a | n/a | SEK 228m |
| Jun 30 2024 | n/a | n/a | SEK 214m |
| Mar 31 2024 | n/a | n/a | SEK 203m |
| Dec 31 2023 | SEK 7m | SEK 3m | SEK 172m |
| Sep 30 2023 | n/a | n/a | SEK 150m |
| Jun 30 2023 | n/a | n/a | SEK 149m |
| Mar 31 2023 | n/a | n/a | SEK 123m |
| Dec 31 2022 | SEK 7m | SEK 3m | SEK 118m |
| Sep 30 2022 | n/a | n/a | SEK 118m |
| Jun 30 2022 | n/a | n/a | SEK 107m |
| Mar 31 2022 | n/a | n/a | SEK 102m |
| Dec 31 2021 | SEK 6m | SEK 3m | SEK 97m |
Compensation vs Market: Anders's total compensation ($USD622.76K) is below average for companies of similar size in the German market ($USD1.28M).
Compensation vs Earnings: Anders's compensation has been consistent with company performance over the past year.
CEO
Anders Dahlberg (50 yo)
Mr. Anders Dahlberg is Chief Executive Officer of MedCap AB (publ) from November 01, 2020. He joined the MedCap AB (publ) on November 01, 2020. He was Director of Stille AB.He joined the Stille AB in 2012...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 5.7yrs | SEK 6.06m | 0.27% € 2.0m | |
| Chief Financial Officer | 6.2yrs | no data | 0.0067% € 50.4k | |
| Business Area Head Specialty Pharma | 2.8yrs | no data | 0.027% € 201.5k | |
| Business Area Head Assistive Tech | no data | no data | no data | |
| Investment Manager | no data | no data | 0.033% € 251.9k |
Experienced Management: 61MA's management team is seasoned and experienced (5.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 4.6yrs | SEK 450.00k | 0.84% € 6.3m | |
| Independent Director | 4.2yrs | SEK 185.00k | no data | |
| Independent Director | 3.5yrs | SEK 185.00k | no data | |
| Independent Director | 4.6yrs | SEK 185.00k | no data | |
| Independent Director | 3.5yrs | SEK 185.00k | no data | |
| Independent Director | 4.2yrs | SEK 185.00k | no data |
Experienced Board: 61MA's board of directors are considered experienced (4.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/27 23:04 |
| End of Day Share Price | 2026/07/27 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MedCap AB (publ) is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Bjorn Rydell | ABG Sundal Collier Sponsored |
| Hans Mähler | Nordea Markets |